MYRIAD GENETICS INC·4

Mar 16, 5:05 PM ET

Fox Jennifer Lynne 4

4 · MYRIAD GENETICS INC · Filed Mar 16, 2026

Research Summary

AI-generated summary of this filing

Updated

Myriad Genetics CLO Jennifer Fox Receives 195,876-Share Award

What Happened Jennifer Lynne Fox, Chief Legal Officer of Myriad Genetics (MYGN), was granted 195,876 restricted stock units (RSUs) on 2026-03-12 (transaction code A). The RSUs have no purchase price (reported $0.00) and represent contingent rights to receive shares. On 2026-03-13 the issuer withheld 5,995 shares to satisfy tax withholding obligations (transaction code F) at $4.66 per share, a disposition valued at $27,937.

Key Details

  • Grant date: 2026-03-12 — 195,876 RSUs granted (acquisition at $0.00, code A).
  • Tax withholding: 2026-03-13 — 5,995 shares withheld @ $4.66 each, total ≈ $27,937 (code F). The withholding was done by the issuer to cover taxes.
  • Vesting: RSUs vest in three equal annual installments beginning on the first anniversary of the grant (per footnote F1).
  • Valuation note: Using the March 13 closing price cited for withholding ($4.66), the grant’s approximate market value would be roughly $912,800.
  • Shares owned after the transactions: not specified in the Form 4.
  • Timeliness: Filing dated 2026-03-16; the Form 4 was filed within the SEC’s reporting window (not late).

Context RSU grants are awards, not open-market purchases, and reflect compensation rather than a direct buy signal. The 5,995-share disposition was a routine issuer withholding to satisfy tax obligations on vested RSUs (not an open-market sale by the insider). The RSUs vest over time, so additional shares may be delivered on future anniversaries per the stated schedule.

Insider Transaction Report

Form 4
Period: 2026-03-12
Fox Jennifer Lynne
Chief Legal Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-12+195,876316,357 total
  • Tax Payment

    Common Stock

    [F2]
    2026-03-13$4.66/sh5,995$27,937310,362 total
Footnotes (2)
  • [F1]Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.
  • [F2]Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026.
Signature
By: Justin Hunter For: Jennifer Lynne Fox|2026-03-16

Documents

1 file
  • 4
    wk-form4_1773695152.xmlPrimary

    FORM 4